News - BioSpace
This year saw lofty highs and devastating lows for neuroscience drug developers like Bristol Myers Squibb, Eli Lilly and AbbVie, following the predictable pattern of successes and failures that characterizes this space.
BioSpace: Biotech, Pharmaceutical and Clinical Research News
Dec 11, 2010 · GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment model; Eli Lilly and Novo Nordisk pump new funds into manufacturing; and AbbVie makes a Cerevel comeback while uniQure clears a path toward accelerated approval in Huntington’s disease.
Join Our Team - BioSpace
BioSpace is the digital hub for life sciences news and jobs. Our mission is to provide essential insights, tools, and opportunities to connect the innovative organizations and talented professionals who advance health and quality of life across the globe.
Wet Lab vs Dry Lab: Challenges, Benefits and Skills Required
Jan 25, 2023 · Wet Lab. Most web labs require at least a degree in chemistry or biology.However, there are some entry-level roles that require only a high school diploma. Soft skills, such as proper handling techniques, are vital in order to work in a wet lab.
About Us - BioSpace
BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
BioSpace - BioSpace
Jul 31, 2024 · BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
FDA Committee Calls For More Research After Moderna’s RSV …
Dec 13, 2024 · The FDA on Tuesday revealed that it has detected severe side effects in two of Moderna ’s experimental mRNA-based respiratory syncytial vaccine candidates, which the biotech is advancing for the immunization of infants.. In a briefing document released ahead of an advisory committee meeting later this week, the regulator’s staffers flagged “an imbalance in severe RSV [lower respiratory ...
Big Pharma’s Interest Grows in Evolving Cell and Gene ... - BioSpace
Oct 9, 2024 · In welcome remarks at the conference on Monday, Alliance for Regenerative Medicine (ARM) CEO Tim Hunt said there has been uptick in investment in cell and gene therapies in 2024, noting that 13 of the 15 largest pharma companies by market capitalization have an “active presence” in the sector.. Hunt said many leading Big Pharma companies—including Astellas, Bayer, BMS, Eli Lilly, Gilead ...
All News - BioSpace
Dec 23, 2024 · The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion in 2023. It’s welcome good news for Vertex following last week’s subpar clinical results for its non-opioid analgesic.
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 ...
Oct 29, 2024 · Third-quarter 2024 Cost of Sales (4) as a percentage of revenues decreased by 39.0 percentage points compared to the prior-year quarter, driven primarily by the non-recurrence of a non-cash charge of $5.6 billion recorded in the third quarter of 2023 for inventory write-offs and related charges ($4.7 billion for Paxlovid and $0.9 billion for Comirnaty (3)).